This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer

This study is currently recruiting participants.
See Contacts and Locations
Verified April 2017 by Wake Forest University Health Sciences
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT00489125
First received: June 20, 2007
Last updated: May 25, 2017
Last verified: April 2017
  Purpose

RATIONALE: Gathering information about strength and range of motion over time from women undergoing surgery for breast cancer may help doctors learn more about recovery from surgery and on-going care.

PURPOSE: This clinical trial is collecting information about strength and range of motion over time from women undergoing surgery for breast cancer.


Condition Intervention
Breast Cancer Other: physiologic testing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Breast Clinic Strength and Range of Motion Study

Resource links provided by NLM:


Further study details as provided by Wake Forest University Health Sciences:

Primary Outcome Measures:
  • Collection of data before surgery, at each follow-up visit, and at 2 years after surgery [ Time Frame: approximately 2 years ]
  • Changes in physical activity participation, measures of body composition, shoulder range of motion, grip strength, and arm strength over time [ Time Frame: approximately 2 years ]
  • Differences in changes in physical activity and indices of fitness according to type of surgery and adjuvant therapy [ Time Frame: approximately 2 years ]
  • Relationships between exercise participation, fitness, and body composition over time [ Time Frame: approximately 2 years ]
  • Correlation of data with an ongoing randomized exercise trial that includes strength and flexibility assessments with no pre-surgery measures [ Time Frame: approximately 2 years ]

Estimated Enrollment: 275
Study Start Date: March 2005
Estimated Study Completion Date: November 2017
Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: physiologic testing
    physical testing of range of motion, grip strength etc.
Detailed Description:

OBJECTIVES:

  • Collect data regarding diagnosis, type of surgery, receipt of adjuvant therapy, age, height, weight, waist circumference, arm strength, grip strength, shoulder range of motion, and physical activity participation from women undergoing surgery for breast cancer.
  • Examine changes in physical activity participation, measures of body composition, shoulder range of motion, grip strength, and arm strength over time in these patients.
  • Determine differences in changes in physical activity and indices of fitness according to type of surgery and adjuvant therapy.
  • Examine relationships between exercise participation, fitness, and body composition over time.
  • Correlate data with an ongoing randomized exercise trial that includes strength and flexibility assessments with no pre-surgery measures.

OUTLINE: This is a prospective, cohort study.

Patients submit data comprising demographic/medical information, anthropometrics (weight, height, waist circumference), grip strength, bicep strength, shoulder range of motion, and physical activity participation prior to surgery, at each surgical follow-up visit, and at 2 years after surgery.

  Eligibility

Ages Eligible for Study:   up to 120 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any woman treated in the Breast Clinic of WFUBMC with a diagnosis of stage 0-IV breast cancer and identified as a candidate by their surgeon.
Criteria

Inclusion Criteria:

  • Diagnosis of breast cancer

    • Stage I-IV disease
  • Planning to undergo surgery at the Comprehensive Cancer Center Breast Clinic at Wake Forest University Baptist Medical Center
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00489125

Locations
United States, North Carolina
Wake Forest University Comprehensive Cancer Center Recruiting
Winston-Salem, North Carolina, United States, 27157-1096
Contact: Clinical Trials Office - Wake Forest University Comprehensive    336-713-6771      
Sponsors and Collaborators
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Investigators
Principal Investigator: Shannon Mihalko, PhD Wake Forest University Health Sciences
Principal Investigator: Edward A. Levine, MD Wake Forest University Health Sciences
  More Information

Responsible Party: Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT00489125     History of Changes
Other Study ID Numbers: CCCWFU 97305
P30CA012197 ( U.S. NIH Grant/Contract )
CCCWFU-97305
CCCWFU-BG05-106
Study First Received: June 20, 2007
Last Updated: May 25, 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Wake Forest University Health Sciences:
long-term effects secondary to cancer therapy in adults
recurrent breast cancer
stage I breast cancer
stage II breast cancer
stage IIIA breast cancer
stage IIIB breast cancer
stage IIIC breast cancer
stage IV breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on September 21, 2017